Skip to main content
Enter your The Contraceptive Pipeline Database username.
Enter the password that accompanies your username.
EVE-106 Novel Estrogen
EVE-106; EVE106; ethinylestradiol prodrugs
EVE-106 is a new chemical entity with validated animal data. A combination of drospirenone (DRSP) and EC-300 (Evestra's test compound), this estrogen receptor agonist is being developed with hopes of utilizing the benefits of DRSP while avoiding the safety issues of ethinyl estradiol (EE).
July 19, 2016
Potential Multi-Purpose Technology (MPT):
Began discovery in:
Prior to 2008
Evestra, Inc. website
Download Product Report